These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 11467592

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Evaluation of L-asparaginase: polyethylene glycol conjugate versus native L-asparaginase combined with chemotherapy. A randomized double-blind study in canine lymphoma.
    MacEwen EG, Rosenthal RC, Fox LE, Loar AS, Kurzman ID.
    J Vet Intern Med; 1992; 6(4):230-4. PubMed ID: 1522554
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. In vitro immune monitoring of antibody response in dogs given chemoimmunotherapy for lymphoma.
    Jeglum KA, Winters WD, Young KM.
    Am J Vet Res; 1989 Apr; 50(4):488-92. PubMed ID: 2712415
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma.
    Simon D, Moreno SN, Hirschberger J, Moritz A, Kohn B, Neumann S, Jurina K, Scharvogel S, Schwedes C, Reinacher M, Beyerbach M, Nolte I.
    J Am Vet Med Assoc; 2008 Mar 15; 232(6):879-85. PubMed ID: 18341445
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of the results of a L-asparaginase-based continuous chemotherapy protocol versus a short doxorubicin-based induction chemotherapy protocol in dogs with malignant lymphoma.
    Piek CJ, Rutteman GR, Teske E.
    Vet Q; 1999 Apr 15; 21(2):44-9. PubMed ID: 10321012
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD, Wolff SN, Stein RS, Greer JP, Cousar JB, Greco FA.
    Cancer Treat Rep; 1986 Aug 15; 70(8):953-8. PubMed ID: 3015406
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Evaluation of cytoreductive efficacy of vincristine, cyclophosphamide, and Doxorubicin in dogs with lymphoma by measuring the number of neoplastic lymphoid cells with real-time polymerase chain reaction.
    Sato M, Yamazaki J, Goto-Koshino Y, Takahashi M, Fujino Y, Ohno K, Tsujimoto H.
    J Vet Intern Med; 2011 Aug 15; 25(2):285-91. PubMed ID: 21314729
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of 3 protocols for treatment after induction of remission in dogs with lymphoma.
    Rassnick KM, McEntee MC, Erb HN, Burke BP, Balkman CE, Flory AB, Kiselow MA, Autio K, Gieger TL.
    J Vet Intern Med; 2007 Aug 15; 21(6):1364-73. PubMed ID: 18196748
    [Abstract] [Full Text] [Related]

  • 38. Combination chemotherapy with vincristine, cyclophosphamide, and prednisone producing long-term remission of a transplanted canine lymphoma.
    Cohen H, Schmidt CE, Lucas SR, Palmer JL.
    Am J Vet Res; 1975 Oct 15; 36(10):1483-7. PubMed ID: 1238040
    [Abstract] [Full Text] [Related]

  • 39. Combination chemotherapy in feline lymphoma: treatment outcome, tolerability, and duration in 23 cats.
    Simon D, Eberle N, Laacke-Singer L, Nolte I.
    J Vet Intern Med; 2008 Oct 15; 22(2):394-400. PubMed ID: 18312554
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.